EditorialsAntibody responses in Crohn’s disease
References (24)
Autoantibodies against intestinal and gastric mucous cells in ulcerative colitis
Lancet
(1965)- et al.
“Atypical p-ANCA” in IBD and Hepatobiliary disorders react with a 50-Kilodalton nuclear envelope protein of neutrophils and myeloid cell lines
Gastroenterology
(2000) - et al.
Identification of a novel bacterial sequence associated with Crohn’s disease
Gastroenterology
(2000) - et al.
Selected loss of tolerance evidenced by Crohn’s disease-associated immune responses to auto- and microbial antigens
Gastroenterology
(2002) - et al.
Diagnostic accuracy of serological assays in pediatric inflammatory bowel disease
Gastroenterology
(1998) - et al.
Diagnostic value of Anti Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease
Am J Gastroenterol
(2001) - et al.
Clinical utility of serodiagnostic testing in suspected pediatric inflammatory bowel disease
Am J Gastroenterol
(2001) - et al.
The value of serologic markers in indeterminate colitisa prospective follow-up study
Gastroenterology
(2002) - et al.
Perinuclear antineutrophil cytoplasmic antibodies in patients with Crohn’s disease define a clinical subgroup
Gastroenterology
(1996) - et al.
Association of antineutrophil cytoplasmic antibodies with resistance to treatment of left-sided ulcerative colitisresults of a pilot study
Mayo Clin Proc
(1996)
Cited by (20)
Inflammatory bowel disease
2019, Emery and Rimoin's Principles and Practice of Medical Genetics and Genomics: Cardiovascular, Respiratory, and Gastrointestinal DisordersInflammatory Bowel Disease
2013, Emery and Rimoin's Principles and Practice of Medical GeneticsInflammatory bowel disease and lupus: A systematic review of the literature
2012, Journal of Crohn's and ColitisCitation Excerpt :Two patients developed drug-induced lupus erythematosus. Antinuclear antibodies were associated with the female sex and skin manifestations.62 According to Mayo clinic experience in 500 patients treated with infliximab and followed-up for 17 months only three patients developed drug-induced lupus.63
Minimizing infliximab toxicity in the treatment of inflammatory bowel disease
2008, Digestive and Liver DiseaseCharacteristics of biological therapy in pediatric patients with Crohn’s disease
2019, Expert Opinion on Biological TherapySerology of Patients with Ulcerative Colitis after Pouch Surgery Is More Comparable with that of Patients with Crohn's Disease
2015, Inflammatory Bowel Diseases
Copyright © 2004 American Gastroenterological Association. Published by Elsevier Inc. All rights reserved.